Cargando…
Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL(Pro) inhibitors
Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe acute respiratory illness with fever, cough and shortness of breath. Up to date, it has resulted in 1826 human infections, including 649 deaths. Analogous to picornavirus 3C protease (3C(pro)), 3C-like protease (3CL(pro)) is criti...
Autores principales: | Kumar, Vathan, Shin, Jin Soo, Shie, Jiun-Jie, Ku, Keun Bon, Kim, Chonsaeng, Go, Yun Young, Huang, Kai-Fa, Kim, Meehyein, Liang, Po-Huang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113684/ https://www.ncbi.nlm.nih.gov/pubmed/28216367 http://dx.doi.org/10.1016/j.antiviral.2017.02.007 |
Ejemplares similares
-
Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
por: Shin, Jin Soo, et al.
Publicado: (2018) -
The Middle East Respiratory Syndrome (MERS)
por: Azhar, Esam I., et al.
Publicado: (2019) -
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017) -
Evaluation and Clinical Validation of Two Field–Deployable Reverse Transcription-Insulated Isothermal PCR Assays for the Detection of the Middle East Respiratory Syndrome–Coronavirus
por: Go, Yun Young, et al.
Publicado: (2017) -
Middle East Respiratory Syndrome (MERS) Coronavirus
por: McFee, R.B.
Publicado: (2020)